Burrows Francis

Track

Insider profile

Performance

Overall performance
3.4
Performance over holding periods
3.4
30 days 90 days 120 days
Average return 11% 8.2% 15.1%
Success rate 96% 68% 82%
Transactions
4 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Burrows Francis's trades of Kura Oncology Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
170.86
Quantity 56,208
Value US$564,126
Transaction date
Sale
Price
402.88
Quantity 66,460 +19.3%
Value US$3,848,515
Transaction date
Sale
Price
101.30
Quantity 79,747 -1.1%
Value US$4,724,910
Transaction date
Proposed sale
Price
9.78
Quantity 23,726
Value US$231,934
Transaction date
Proposed sale
Price
7.77
Quantity 2,166
Value US$16,830
Transaction date
Sale
Price
7.87
Quantity 1,320 -6.0%
Value US$10,391
Transaction date
Sale
Price
7.87
Quantity 846 -3.7%
Value US$6,660
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-01-27 2026-01-27
PrS Proposed sale
56,208
170.86
US$564,126 		56,208 170.86 US$564,126
2026-01-27 2026-01-27
S Sale
66,460 +19.3%
402.88
US$3,848,515 		66,460 +19.3% 402.88 US$3,848,515
2025-12-19 2025-12-18
S Sale
79,747 -1.1%
101.30
US$4,724,910 		79,747 -1.1% 101.30 US$4,724,910
2025-12-18 2025-12-18
PrS Proposed sale
23,726
9.78
US$231,934 		23,726 9.78 US$231,934
2025-01-28 2025-01-28
PrS Proposed sale
2,166
7.77
US$16,830 		2,166 7.77 US$16,830
2025-01-28 2025-01-28
S Sale
1,320 -6.0%
7.87
US$10,391 		1,320 -6.0% 7.87 US$10,391
2025-01-28 2025-01-28
S Sale
846 -3.7%
7.87
US$6,660 		846 -3.7% 7.87 US$6,660